ArticleResearch (Washington, D.C.)2025
SpatConv Enables the Accurate Prediction of Protein Binding Sites by a Pretrained Protein Language Model and an Interpretable Bio-spatial Convolution.
Article in Research (Washington, D.C.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Protein-nucleic acid binding site prediction using interpretable Kolmogorov-Arnold networks with hypergraph representation learning.Bioinformatics (Oxford, England) · 2026Article
- NanoBind: Mechanism-Driven Deep Learning of Nanobody-Antigen Molecular Recognition.Research (Washington, D.C.) · 2026Article
- Physics-Informed Artificial Intelligence Design of Picomolar Nanobodies Enables Deep Tumor Penetration and High-Contrast Imaging.Research (Washington, D.C.) · 2026Article
- DTBind: A Mechanism-Driven Deep Learning Framework for Accurate Prediction of Drug-Target Molecular Recognition.Research (Washington, D.C.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Protein interactions with molecules, such as other proteins, peptides, or small ligands, play a critical role in biological processes, and the identification of protein binding sites is crucial for understanding the mechanisms underlying diseases such as cancer. Traditional protein binding site prediction models usually extract residue features manually and then employ a graph or point-cloud-based architecture borrowed from other fields. Therefore, substantial information loss and limited learning ability cause them to fail to capture residue binding patterns. To solve these challenges, we introduce a general network that predicts the binding residues of proteins, peptides, and metal ions on proteins. SpatConv extracts sequence features from a pretrained large protein language model and structure features from a local coordinate framework. SpatConv learns residue binding patterns through a specially designed, graph-free bio-spatial convolution, which characterizes the complex spatial environments around the residues. After training and testing, SpatConv demonstrates great improvements over the state-of-the-art predictors and reveals novel biological insights into the relationship between binding sites and physicochemical properties. Notably, SpatConv exhibits robust performance across predicted and experimental structures, enhancing its reliability. Additionally, when applying it to the spike protein structure of severe acute respiratory syndrome coronavirus 2, SpatConv successfully identifies antibody binding sites and predicts potential binding regions, providing strong evidence supporting new drug development. A user-friendly online server for SpatConv is freely available at http://liulab.top/SpatConv/server.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.